Glioma progression is also supported by astrocytic release of CC chemokine ligand 2 (CCL2) and colony-stimulating factor 1 (CSF1), leading to recruitment of tumor-associated macrophages with a pro-tumor phenotype [137]. Here, CCL2 is linked to neoplasm.